JeniVision is an innovative biopharmaceutical company that strives to discover advanced therapies for eye and skin diseases. With our creativity and ingenuity, we hope to create pathways in medicine for the future.
Jenny Wang, Ph.D
Chief Executive Officer
Dr. Wang is an entrepreneur, an inventor, and a scientist. She leads the efforts of business strategies on obtaining financing and drug development, establishing partnerships, identifying contracted services, as well as deeply involved in pharmaceutical R&D and invention. She is well-trained in pharmacology, biochemistry, and molecular and cellular biology. Her therapeutic interests are ophthalmology, inflammation and hair growth, with about 40 patents and over 20-year experience in pharmaceutical and biotechnology industry. She is the former Allergan Research Investigator and the team leader for hair growth research of the Latisse franchise. https://www.linkedin.com/in/dr-jennywwang
David Woodward, Ph.D
Chief Scientific Officer
Dr. Woodward is a researcher with extensive experience and exceptional accomplishment. He has received major awards, including two honorary professorships at Imperial College London and at University of Bradford in the UK. He also received the inaugural Distinguished Scientist Award at Allergan Pharmaceuticals and is the former Allergan Senior Research Investigator. He is an inventor of almost 100 issued US patents, and the primary inventor of two commercially successful products, Lumigan and Latisse with combined annual sales of ~$1 billion for Allergan. His major research interests include inflammation, dermatology, ophthalmology, itch, and pain. https://www.linkedin.com/in/david-f-woodward-120609137?
Nonna Snider, BS
VP Clinical & Operations
Mrs. Snider joined JeniVision in March of 2020. She has over 20 years in pre-clinical and clinical drug development in both Pharmaceutical Industry and Academia. She has served as Assistant Director for Clinical Operations, responsible for ensuring safe and compliant implementation of Phase I, II and III oncology clinical trials conducted at the USC Norris Comprehensive Cancer Center, as well as basic researcher and Project Manager in pharmaceutical industry conducting pre-clinical and clinical research in US, India and Latin America, taking 1 Dermatology and 2 oncology compounds through pre-clinical and Phase I and II clinical trials